Adverse Event Risk After LAMS Placement for Pancreatic Fluid Collections

PFC size ≤7 cm and stent removal after 4 weeks were independent predictors of hemorrhage or buried stent.

Conflicting data exist regarding adverse event rates of drainage of pancreatic fluid collections (PFCs) with the now commonly used lumen-apposing metal stent (LAMS). Recently, researchers at one high-volume center retrospectively evaluated incidence and characteristics of delayed adverse events at 6-month follow-up in 188 patients who underwent endoscopic PFC drainage (of pseudocyst in 31% and pancreatic necrosis in 69%). Results were as follows:

Twelve patients (6.4%) developed serious adverse events: hemorrhage in eight and buried stent in four.
Five bleeding events were due to involvement of large vessels such as the gastroduodenal artery or the splenic artery and were treated via interventional radiology embolization. Three were mucosal b…

Reviewing Author

Douglas G. Adler, MD, FACG, AGAF, FASGE

Disclosures

Consultant/Advisory BoardBSC; Merit; Olympus

Speaker’s BureauAbbVie

Editorial BoardsGastrointestinal Endoscopy

Douglas G. Adler, MD, FACG, AGAF, FASGE

Disclosures

Consultant/Advisory BoardBSC; Merit; Olympus

Speaker’s BureauAbbVie

Editorial BoardsGastrointestinal Endoscopy

Adverse Event Risk After LAMS Placement for Pancreatic Fluid Collections

Topics

Reviewing Author